Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001140361-18-018863

President & CEO acquired 27,007 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Murray Mark J. · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-04-17 Exercise or conversion : show line 1 in the form +27,007 $0.35 $9,560 316,396 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-04-16 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +418,187 418,187 D
2018-04-17 Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) −27,007 0 D
Loading xslF345X03/doc1.xml…